Viewing Study NCT00112502


Ignite Creation Date: 2025-12-25 @ 3:40 AM
Ignite Modification Date: 2026-03-05 @ 8:51 AM
Study NCT ID: NCT00112502
Status: COMPLETED
Last Update Posted: 2021-10-18
First Post: 2005-06-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain and Central Nervous System Tumors View
None Glioblastoma Multiforme View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult giant cell glioblastoma View
None adult gliosarcoma View
None adult glioblastoma View